The offer is the company’s third attempt to resolve tens of thousands of claims that its baby powder caused ovarian cancer and mesothelioma.
Category: Johnson & Johnson
-
FDA Issues Alert on Heart Pump Linked to Deaths
The agency faulted the device maker for delayed notice of mounting complications, citing increasing reports of how use of the device perforated the walls of the heart.
-
J&J, Merck and Bristol Myers Squibb CEOs Will Testify at Senate Hearing on Drug Prices
The top executives of three major companies are set to appear on Thursday before a Senate panel led by Mr. Sanders, who has made lowering drug costs a signature issue.
-
Judge Rejects Johnson & Johnson’s Effort to Limit Talc-Related Liabilities
A bankruptcy court’s ruling was the second time the company was rebuffed in its attempt to settle thousands of lawsuits that claim its products caused cancer.
-
Drugmakers Throw ‘Kitchen Sink’ to Halt Medicare Price Negotiations
The government will soon announce the first 10 medications that will be subject to price negotiations with Medicare under a new law. Drugmakers are fighting the measure in court.
-
Europe Plots a Diplomatic and Business Reset on China
President Emmanuel Macron of France and Ursula von der Leyen, President of the European Commission, arrived in China on Wednesday aiming to restart business and political ties.
-
Johnson & Johnson Reaches $8.9 Billion Talc Settlement
The company faces a flood of lawsuits claiming its talc products caused cancer. The proposed settlement requires approval by a bankruptcy court, but has the backing of plaintiffs’ lawyers.
-
Covid Vaccine Makers Kept Prepayments for Canceled Shots for Poor Nations
The New York Times – Business:Separately, Johnson & Johnson is demanding additional payment for unwanted shots, confidential documents show.
-
Johnson & Johnson’s Talc-Related Bankruptcy Filing Is Rejected
The New York Times – Business:The company faces some 40,000 plaintiffs that claim its baby powder caused cancer.
-
The Only H.I.V. Vaccine in Advanced Trials Has Failed. What Now?
The New York Times – Business:Janssen Pharmaceuticals ended a global trial after independent experts determined the vaccine was not effective. But there are other possibilities in the pipeline, scientists said.